Kinase Genotyping of Gastro Intestinal Stomach Tumors (GISTs) From Patients Enrolled in Pfizer A6181112 Phase IIIb Trial

WithdrawnOBSERVATIONAL
0
Timeline

Start Date

December 31, 2007

Primary Completion Date

September 30, 2009

Study Completion Date

April 30, 2011

Conditions
Gastrointestinal Neoplasm
Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

Oregon Health and Science University

OTHER

NCT00640692 - Kinase Genotyping of Gastro Intestinal Stomach Tumors (GISTs) From Patients Enrolled in Pfizer A6181112 Phase IIIb Trial | Biotech Hunter | Biotech Hunter